Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid or Mefenamic Acid for Mirena-Associated Bleeding
NCT01295294Phase 4Completed
- Sponsor
- Bayer
- Start
- Mar 2011
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 4 trial of tranexamic acid, Mefenamic acid in Abnormal uterine bleeding (AUB), sponsored by Bayer. Started Mar 2011; status: completed.
02
Drugs
tranexamic acidMefenamic acid
03
Conditions
Abnormal uterine bleeding (AUB)
Beyond the preview
Go deeper on NCT01295294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01295294.